Home Federal Bank of Tennessee’s Pfizer PFE Stock Holding History

Home Federal Bank of Tennessee’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$718K	Buy	29,837 +4,700	+19%	+$123K	0.16%	58
2026 Q1	$706K	Buy	25,137 +5,500	+28%	+$146K	0.18%	51
2025 Q4	$489K	Hold	19,637	–	–	0.13%	59
2025 Q3	$500K	Sell	19,637 -1,121	-5%	-$27.7K	0.13%	56
2025 Q2	$503K	Sell	20,758 -5,777	-22%	-$135K	0.14%	55
2025 Q1	$672K	Sell	26,535 -769	-3%	-$20.1K	0.2%	53
2024 Q4	$724K	Sell	27,304 -425	-2%	-$11.5K	0.21%	50
2024 Q3	$802K	Buy	27,729 +269	+1%	+$7.85K	0.23%	53
2024 Q2	$768K	Buy	27,460 +647	+2%	+$17.8K	0.23%	51
2024 Q1	$744K	Buy	26,813 +175	+0.7%	+$4.86K	0.23%	51
2023 Q4	$767K	Buy	26,638 +15	+0.1%	+$453	0.26%	49
2023 Q3	$883K	Sell	26,623 -183	-0.7%	-$6.47K	0.33%	44
2023 Q2	$983K	Sell	26,806 -943	-3%	-$36.7K	0.35%	42
2023 Q1	$1.13M	Sell	27,749 -200	-0.7%	-$8.64K	0.42%	36
2022 Q4	$1.43M	Buy	27,949 +587	+2%	+$28.1K	0.54%	33
2022 Q3	$1.2M	Sell	27,362 -50	-0.2%	-$2.43K	0.5%	35
2022 Q2	$1.44M	Buy	27,412 +300	+1%	+$15.3K	0.56%	32
2022 Q1	$1.4M	Buy	27,112 +530	+2%	+$27.5K	0.48%	31
2021 Q4	$1.57M	Sell	26,582 -2,800	-10%	-$139K	0.52%	29
2021 Q3	$1.26M	Buy	29,382 +1,070	+4%	+$47.4K	0.46%	35
2021 Q2	$1.11M	Sell	28,312 -1,795	-6%	-$69.8K	0.4%	38
2021 Q1	$1.09M	Sell	30,107 -1,700	-5%	-$60.4K	0.41%	39
2020 Q4	$1.17M	Sell	31,807 -1,117	-3%	-$41K	0.46%	37
2020 Q3	$1.15M	Hold	32,924	–	–	0.5%	37
2020 Q2	$1.02M	Hold	32,924	–	–	0.47%	37
2020 Q1	$1.02M	Buy	32,924 +179	+0.5%	+$6.1K	0.56%	35
2019 Q4	$1.22M	Buy	32,745 +338	+1%	+$12K	0.51%	38
2019 Q3	$1.1M	Buy	32,407 +168	+0.5%	+$6.11K	0.5%	39
2019 Q2	$1.32M	Buy	32,239 +1,197	+4%	+$47.5K	0.61%	35
2019 Q1	$1.25M	Sell	31,042 -257	-0.8%	-$10.3K	0.59%	38
2018 Q4	$1.3M	Buy	31,299 +263	+0.8%	+$10.9K	0.68%	33
2018 Q3	$1.3M	Buy	31,036 +1,006	+3%	+$38.7K	0.6%	38
2018 Q2	$1.03M	Buy	30,030 +6,973	+30%	+$238K	0.5%	42
2018 Q1	$777K	Buy	23,057 +437	+2%	+$15K	0.39%	43
2017 Q4	$777K	Sell	22,620 -263	-1%	-$8.97K	0.38%	46
2017 Q3	$775K	Sell	22,883 -158	-0.7%	-$5.08K	0.4%	46
2017 Q2	$734K	Hold	23,041	–	–	0.39%	45
2017 Q1	$748K	Sell	23,041 -923	-4%	-$29.1K	0.41%	45
2016 Q4	$739K	Hold	23,964	–	–	0.42%	45
2016 Q3	$770K	Buy	23,964 +509	+2%	+$17K	0.45%	43
2016 Q2	$783K	Sell	23,455 -238	-1%	-$7.6K	0.47%	43
2016 Q1	$667K	Hold	23,693	–	–	0.42%	44
2015 Q4	$725K	Buy	+23,693	New	+$745K	0.48%	43

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Home Federal Bank of Tennessee's PFE Position: Q2 2026 in Review

Home Federal Bank of Tennessee increased its Pfizer (PFE) stake by 19% in Q2 2026, buying an estimated $123K and bringing the position to 29,837 shares worth $718K. The position accounts for 0.16% of the portfolio, ranked #58.

Home Federal Bank of Tennessee first reported a position in PFE in Q4 2015 and has held it in 43 quarters since. The position peaked at $1.57M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Home Federal Bank of Tennessee held 29,837 shares of Pfizer worth $718K as of Q2 2026.
Home Federal Bank of Tennessee bought 4,700 Pfizer shares in Q2 2026, an estimated $123K.
Pfizer made up 0.16% of Home Federal Bank of Tennessee's portfolio in Q2 2026, its #58 holding.
Home Federal Bank of Tennessee first reported a position in Pfizer in Q4 2015 and has held it in 43 quarters since.
Home Federal Bank of Tennessee's Pfizer position peaked at $1.57M in Q4 2021.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Home Federal Bank of Tennessee's 13F filing for Q2 2026, filed 15 Jul 2026.